Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02330835 · ClinicalTrials.gov registry record · Phase 2
Multimedia Program to Promote Positive Bus Behavior
A Phase 2 study of Student Behavior, sponsored by Oregon Center for Applied Science.
- Completed
- Registry status
- Phase 2
- Development phase
- 710
- Enrollment target
- 1
- Study location
NCT02330835: Completed Phase 2 study of Student Behavior, sponsored by Oregon Center for Applied Science.
NCT02330835 is a Phase 2 study of Student Behavior that has completed, run by Oregon Center for Applied Science. The registered enrollment target is 710 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (434% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02330835, a Phase 2 study of Student Behavior, has completed, sponsored by Oregon Center for Applied Science.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 710 participants
- Enrollment target
- 1
- Study location
Study Summary
This project evaluated a multimedia student behavior management program for school bus drivers and school administrators.
Primary Outcome
The Attitudes and Beliefs regarding Bus Climate items consisted of a total of 27 questions that assessed drivers in the following areas: (1) relationships with students; (2) understanding how to respond to student behavior; (3) interactions with students; (4) drivers' perception of their own bus climate; (5) communication with other drivers; and (6) departmental support for behavior management. For each of the attitudes and beliefs items, drivers were asked how much they agreed, or disagreed, wi
Conditions Studied
Interventions
- BEHAVIORAL In the Drivers Seat
- BEHAVIORAL School bus driver training videos
Study Locations (1)
Oregon
- Oregon Center for Applied Science - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 710 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
What the finished NCT02330835 record still lists
NCT02330835 is an interventional study that assigns participants to a tested intervention. The registered 710 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (434% higher).
The record links to 1 condition, with Student Behavior appearing as the primary indexed condition, and to 2 interventions - of which In the Drivers Seat is the first listed.
NCT02330835 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT02330835 about?
NCT02330835 is a clinical study titled "Multimedia Program to Promote Positive Bus Behavior". This project evaluated a multimedia student behavior management program for school bus drivers and school administrators.
What is the current status of trial NCT02330835?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 710 participants. The study started on 2007-01. Estimated completion is 2007-07.
What conditions does trial NCT02330835 study?
This clinical trial studies the following conditions: Student Behavior.
What interventions are being tested in trial NCT02330835?
The interventions under investigation include: In the Drivers Seat (BEHAVIORAL), School bus driver training videos (BEHAVIORAL).
Who is sponsoring clinical trial NCT02330835?
This trial is sponsored by Oregon Center for Applied Science, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02330835 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02330835's enrollment target sits among peer trials
710 45th of 2000 higher than 1,956 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia